Product Description.:
NGL, 12.5
Tablet , film-coated , pink , oval oblong
DebossedBiconvex
Movantik/Moventig (naloxegol) is an oral peripherally acting mu-opioid receptor antagonist (PAMORA). In the US, Movantik is indicated for the treatment of OIC in adult patients with chronic, non-cancer pain. In the EU, Moventig is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).